Gene:
VTCN1
V-set domain containing T cell activation inhibitor 1

Overview

Alternate Names: OTTHUMP00000013947; T cell costimulatory molecule B7x; immune costimulatory protein B7-H4
Alternate Symbols: B7-H4; B7H4; B7S1; B7X; B7h.5; FLJ22418; PRO1291; RP11-229A19.4; VCTN1
PharmGKB Accession Id: PA142670611

Details

Cytogenetic Location: chr1 : p13.1
GP mRNA Boundary: chr1 : 117487737 - 117555070
GP Gene Boundary: chr1 : 117484737 - 117565070
Strand: minus
Product Name: T cell costimulatory molecule B7x, V-set domain containing T cell activation inhibitor 1, immune costimulatory protein B7-H4
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

Non-Curated Annotations (Non-Curated Annotation)

  1. rs12046117 at chr1:117552888 in VTCN1
    GWAS results: Identification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysis. (Initial Sample Size: 279 cases, 184 controls; Replication Sample Size: up to 654 cases, 1,847 controls); (Region: 1p13.1; Reported Gene(s): VTCN1; Risk Allele: rs12046117-?); (p-value= 0.000001).This variant is associated with Juvenile idiopathic arthritis.
    Related Diseases:
    Arthritis
    Evidence:
    PMID:19116933
    http://www.genome.gov/gwastudies/
Variant names are different names that have been used in the literature and other resources to refer to the same variant. Non-curated variant information is accumulated solely by computational methods and has not been verified by the scientific staff at PharmGKB.

Non-Curated Information

A list of non-curated publications that mention this gene along with other diseases is available.

The PharmGKB is financially supported by the NIH/ NIGMS and is managed at Stanford University (U01GM61374).
©2001-2010 PharmGKB.